Trimurthi Limited

Equities

TRIMURTHI6

INE314I01036

Investment Banking & Brokerage Services

Delayed Bombay S.E. Other stock markets 03:30:56 01/07/2024 pm IST			5-day change	1st Jan Change
18.94 ^INR	0.00%		0.00%	+68.36%

25/06	Trimurthi Limited announced that it has received INR 18.5 million in funding	CI
11/06	Trimurthi Limited announced that it expects to receive INR 19 million in funding	CI

Trimurthi Drugs & Pharmaceuticals Ltd Announces Resignation of Arvind Kumar Bhangadia as Managing Director

September 01, 2015 at 06:27 pm IST

Trimurthi Drugs & Pharmaceuticals Ltd. announced that the Board of Directors of the company at its meeting held on September 01, 2015, considered the resignation of Mr. Arvind Kumar Bhangadia from the position of Managing director. However the board has accepted the resignation and requested him to continue till the appointment of new Managing director.

Latest news about Trimurthi Limited

Trimurthi Limited announced that it has received INR 18.5 million in funding	25/06	CI
Trimurthi Limited announced that it expects to receive INR 19 million in funding	11/06	CI
Trimurthi Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	28/05	CI
Trimurthi Limited Reports Earnings Results for the Full Year Ended March 31, 2024	28/05	CI
Srinidhi Fine-Chemicals LLP along with vupparapalli chandrashekar reddy entered into share purchase agreement to acquire 49.71% stake in Trimurthi Limited from group of sellers for INR 50.7 million.	05/03	CI
Srinidhi Fine-Chemicals LLP and Vupparapalli Chandrasekhar Reddy made an offer to acquire 26% stake in Trimurthi Limited for INR26.5 million.	05/03	CI
Trimurthi Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	30/01	CI
Trimurthi Narrows Net Loss in Fiscal Q2	17/23/17	MT
Trimurthi Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	17/23/17	CI
Trimurthi Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	08/23/08	CI
Trimurthi Names Chairman	10/23/10	MT
Trimurthi Limited Announces Directorate Changes	09/23/09	CI
Trimurthi Limited Announces Managing Director Changes	09/23/09	CI
Trimurthi Divests Entire Stake in Curova India	16/23/16	MT
Arun Kumar Bhangadia completed the acquisition of 25% stake in Curova India LLP.	16/23/16	CI
Trimurthi Completes Sale of Wholly-Owned Subsidiary	05/22/05	MT
Trimurthi Limited acquired Trimurthi Pharmaceuticals Private Limited for approximately INR 4 million.	04/22/04	CI
Trimurthi Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	10/22/10	CI
Trimurthi Limited Reports Earnings Results for the Full Year Ended March 31, 2022	28/22/28	CI
Arun Kumar Bhangadia agreed to acquire 25% stake in Curova India LLP for INR 3.25 million.	28/22/28	CI
Trimurthi Limited Appoints Monam Kapoor as Additional Director	07/22/07	CI
Trimurthi Completes Sale of Wholly-Owned Arm	28/22/28	MT
Trimurthi Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	12/22/12	CI
Trimurthi Limited Announces Board and Committee Changes	12/22/12	CI
Trimurthi Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	12/21/12	CI

Chart Trimurthi Limited

Duration

Period

More charts

Company Profile

Trimurthi Limited is an India-based company, which is engaged in the business of trading of pharmaceuticals and related products and is into the business of trading of shares and securities. The Company's segments include Pharma Business, Financial Services, Investments, Trading in Shares and Foods. Its services include distribution network for pharmaceutical products, retail pharmacy and marketing. Its products include T-SIF-O, Polyflic XT, Ulcizole-DSR, Auscomin-S, T-SIF 200, ACLO-P, LAMITAB, Oriflox, Treb-DSR, Conplus and Volivia Gold.

Sector

Investment Banking & Brokerage Services

Calendar

07/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Banking & Brokerage Services

	1st Jan change	Capi.
TRIMURTHI LIMITED	+68.36%	2.27M
MORGAN STANLEY	+6.86%	162B
THE GOLDMAN SACHS GROUP, INC.	+20.70%	158B
CHARLES SCHWAB	+7.78%	136B
CITIGROUP INC.	+25.74%	123B
CITIC SECURITIES COMPANY LIMITED	-10.70%	34.35B
RAYMOND JAMES FINANCIAL, INC.	+9.49%	25.3B
LPL FINANCIAL HOLDINGS INC.	+23.89%	21.07B
CSC FINANCIAL CO., LTD.	-19.28%	17.91B
NOMURA HOLDINGS, INC.	+50.78%	17.6B

Other Investment Banking & Brokerage Services